Carbamazepine and Dysmorphism - a phase IV clinical study of FDA data

Summary:

Dysmorphism is reported as a side effect among people who take Carbamazepine (carbamazepine), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Folic Acid, and have Foetal exposure during pregnancy.

The phase IV clinical study analyzes which people have Dysmorphism when taking Carbamazepine. It is created by eHealthMe based on reports of 43,715 people who have side effects when taking Carbamazepine from the FDA, and is updated regularly.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.

What is Dysmorphism?

Dysmorphism (difference of body structure that is suggestive of a congenital disorder) is found to be associated with 175 drugs and 227 conditions by eHealthMe. Check the latest studies of Dysmorphism.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

43,715 people reported to have side effects when taking Carbamazepine.
Among them, 179 people (0.41%) have Dysmorphism.

Among these 179 people:

* Approximation only. Some reports may have incomplete information.

Do you take Carbamazepine and have Dysmorphism?

- Check whether Dysmorphism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carbamazepine:

Carbamazepine (44,628 reports)

Dysmorphism treatments and more:

Dysmorphism (3,153 reports)

How severe was Dysmorphism and when was it recovered:

Dysmorphism in Carbamazepine

Expand to all the drugs that have ingredients of carbamazepine:

Dysmorphism and drugs with ingredients of carbamazepine (206 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysmorphism:

Dysmorphism (175 drugs)

Browse all the conditions that are associated with Dysmorphism:

Dysmorphism (227 conditions)

Related publications that referenced our studies

Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Carbamazepine) and Carbamazepine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.